Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_assertion type Assertion NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_head.
- NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_assertion description "[The initial aim of this study was to identify protein changes associated with long-term morphine treatment in a recombinant human neuroblastoma SH-SY5Y clone (sc2) stably overexpressing the human mu-opioid (MOP) receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_provenance.
- NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_assertion evidence source_evidence_literature NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_provenance.
- NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_assertion SIO_000772 15901846 NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_provenance.
- NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_assertion wasDerivedFrom befree-20140225 NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_provenance.
- NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_assertion wasGeneratedBy ECO_0000203 NP173072.RA3ioGxoWnZjWIc6ERAJM2oOUr7btuOEMZYMFtN2UQ5Cw130_provenance.